Consonance Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Consonance Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,294	Closed	-$254K	–	6
2022 Q2	$254K	Sell	4,294 -143,033	-97%	-$11.7M	1.07%	6
2022 Q1	$17.1M	Sell	147,327 -153,337	-51%	-$17.9M	29.07%	1
2021 Q4	$45.3M	Sell	300,664 -186,663	-38%	-$25.2M	29.52%	1
2021 Q3	$58.2M	Sell	487,327 -491,899	-50%	-$54.2M	31.84%	1
2021 Q2	$95.4M	Buy	+979,226	New	+$87.3M	11.48%	3
2020 Q1	–	Sell	-550,956	Closed	-$32.8M	–	38
2019 Q4	$32.8M	Sell	550,956 -471,301	-46%	-$29.1M	2%	21
2019 Q3	$60.3M	Buy	+1,022,257	New	+$65.3M	5.97%	5

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Consonance Capital Management's TNDM Position: Q3 2022 in Review

Consonance Capital Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 4,294 shares — an estimated $254K sold.

Consonance Capital Management first reported a position in TNDM in Q3 2019 and held it in 7 quarters. The position peaked at $95.4M in Q2 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

Consonance Capital Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
Consonance Capital Management sold 4,294 Tandem Diabetes Care shares in Q3 2022, an estimated $254K.
Consonance Capital Management first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 7 quarters.
Consonance Capital Management's Tandem Diabetes Care position peaked at $95.4M in Q2 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Consonance Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.